NCT05051059 2026-03-16
QOLSarcoma
Universitaire Ziekenhuizen KU Leuven
Phase NA Recruiting
Clinical Trials
31 trialsNCT03442465 2026-03-04
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Memorial Sloan Kettering Cancer Center
Recruiting
NCT05108298 2026-03-02
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT07193550 2026-02-27
A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT04055220 2026-02-17
REGOSTA
Centre Leon Berard
Phase NA Recruiting
NCT04698785 2026-02-17
REGOMAIN
Centre Leon Berard
Phase 2 Recruiting
NCT02677961 2026-02-11
An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Ohio State University Comprehensive Cancer Center
Recruiting
NCT05726383 2026-02-10
Iscador® P (Mistletoe) Immunotherapy for Recurrent Osteogenic Sarcoma
Hackensack Meridian Health
Phase 2 Recruiting
NCT06409013 2026-02-06
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
Mayo Clinic
Recruiting
NCT05779670 2026-02-03
ADER
Istituto Ortopedico Rizzoli
Recruiting
NCT05419518 2026-01-23
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT07197645 2026-01-13
SOLACE
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 1 Recruiting
NCT07259304 2025-12-02
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
University of Southern California
Recruiting
NCT02811523 2025-11-26
In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma
University Health Network, Toronto
Phase 1 Recruiting
NCT03093909 2025-11-10
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT06720142 2025-11-03
Mg OSTEOCRETE Post-Treatment Outcomes
Massachusetts General Hospital
Recruiting
NCT03160274 2025-10-15
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
The University of Texas Health Science Center at San Antonio
Recruiting
NCT07215611 2025-10-10
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
M.D. Anderson Cancer Center
Recruiting
NCT04515459 2025-09-15
EPOP-SARCOMA
Institut Claudius Regaud
Phase 2 Recruiting
NCT06335251 2025-08-28
Radiotherapy Treatments for Neoplasms of the Limbs
European Institute of Oncology
Recruiting
NCT06129903 2025-05-16
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT06935864 2025-04-20
Tissue Expression of Krüppel-Like Factors 4 and 7 in Bone Tumors
Ain Shams University
Recruiting
NCT06881498 2025-04-15
A Substudy of the Effect of Acute Normovolemic Hemodilution in Bone Tumor Surgery
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Recruiting
NCT06486506 2025-04-01
ProFemuRe
Istituto Ortopedico Rizzoli
Recruiting
NCT04181970 2025-03-21
(SELNET)
Grupo Espanol de Investigacion en Sarcomas
Recruiting
NCT06459141 2025-03-14
The Effect of Acute Normovolemic Hemodilution in Bone Tumor Surgery
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Recruiting
NCT06669013 2024-11-01
FollowTheDIN
N.N. Petrov National Medical Research Center of Oncology
Phase 3 Recruiting
NCT05057130 2024-04-01
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Phase 2/3 Recruiting
NCT06302465 2024-03-29
Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells
Peking University People's Hospital
Phase NA Recruiting
NCT06171282 2023-12-14
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Recruiting
NCT04394052 2020-07-21
TUMOSTEO II
Central Hospital, Nancy, France
Recruiting